However, IFN-γ signaling in tumor cells leads to the upregulation of programmed death ligand-1 (PD-L1) to inactivate T cells through programmed cell death protein-1 (PD-1) and to enhance protumorigenic T cells. The gene discussed is IFNG; the disease is neoplasm.